Time flies with great content! Renew in to keep enjoying all our premium content.
Prime
Why we should promote clinical trials in sub-Saharan Africa’s disease battle
Historically, global clinical research has been disproportionately concentrated in well-resourced countries. The majority of new treatments, including those for cancer, heart disease, and diabetes, have been developed and tested in Western populations.
On May 20, the world marked World Clinical Trials Day, a moment to reflect on the critical role that research plays in the advancement of modern medicine.
This year’s theme, ‘Rethinking Clinical Trials: Inclusivity in Practice,’ is not only timely, but also urgent. For sub-Saharan Africa, a region characterised by immense genetic diversity, a growing disease burden, and historically underrepresented populations, the call for greater inclusivity in clinical research must be heeded.
